Search Results

Press Releases

PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint

October 28, 2024

·

5 min read

Policy

Fourth Generation CathWorks FFRangio® System Receives Regulatory Approval in Japan

CathWorks announced today the approval of the fourth generation CathWorks FFRangio® System by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

October 6, 2022

·

2 min read

Business

Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a strategic partnership agreement with CathWorks, a privately held company headquartered in Kefar Sava, Israel, which aims to transform how coronary artery disease (CAD) is diagnosed and treated.

July 12, 2022

·

6 min read

Biotech Beach

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System, making it more broadly available for coronary artery disease decision-making in Japan.

July 26, 2021

·

3 min read

Business

CathWorks Announces Appointment of Ramin Mousavi as Chief Executive Officer and Board Member

CathWorks, a global leader of digital health innovation focused on helping patients with cardiovascular disease, today announced that Ramin Mousavi has been appointed Chief Executive Officer, effective June 21, 2021.

June 14, 2021

·

3 min read

Biotech Beach

CathWorks FFRangio™ System Featured In TCT 2019 Satellite Program

CathWorks today announced The CathWorks FFRangio™ System will be featured in a Satellite Program held during the 2019 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Francisco.

September 20, 2019

·

2 min read

Policy

CathWorks FFRangio™ System Receives Regulatory Approval in Japan

The CathWorks FFRangio System transforms routine angiogram images into objective and comprehensive physiology information, including a color-coded 3D renderings of blood flow in the heart’s arteries to help physicians optimize coronary artery disease decision making, including whether a stent is needed.

December 11, 2019

·

2 min read

Business

CathWorks Names Paul Kapsner as Vice-President of Sales

Provides Experienced Commercial Leadership For CathWorks FFRangio™ U.S. Launch

December 27, 2018

·

2 min read

Policy

CathWorks FFRangio™ System Files FDA 510(k) Submission

CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.

August 22, 2018

·

2 min read

CathWorks FAST-FFR Trial Enrollment Completed Early

CathWorks announced that its FAST-FFR trial is fully enrolled ahead of schedule.

August 15, 2018

·

2 min read